| Аудиторские |  Игры |  Промышленность |  Торговля |  Нефтеные |  Строительство |  Трейдеры |  Инвестиционные |  Юридические |  Оффшорные |  Автомобили |  Страхование |  Комуникации |  Химические компании |  Программы | 
 
Pfizer, Incorporated (NYSE: PFE)

Price and Chart delayed at least 15 mintues.
Price $ 14.48 Change 0.00
Open 0.00 % Change 0.0%
Prev Close 14.48 Volume NA
Market Value 98 bil P/E Ratio 12.2
Bid 14.24 EPS 1.19
Ask 15.02 Dividend 0.64
High 0.00 Yield 4.4
Low 0.00 Shares Out 6.75 bil
52wk High 20.13 52wk Low 11.62
Industry: Drug Manufacturers - Major
Sector: Healthcare

PFE Profile

A research-based, global pharmaceutical company which discovers, develops, manufactures and markets prescription medicines for humans and animals.

Pfizer, Inc.
235 East 42nd Street
New York, NY 10017-5755
Phone: (212) 573-2323
Fax: (212) 573-7851
Web Site: www.pfizer.com

PFE Wires Headlines

07.02.09  Final Glance: Pharmaceuticals companies
07.02.09  Midday Glance: Pharmaceuticals companies
07.02.09  RPT-UPDATE 3-J&J buys $1 bln Elan stake, gains Alzheimer's R&D
07.02.09  UPDATE 3-J&J buys $1 bln Elan stake, gains Alzheimer's R&D
07.02.09  Early Glance: Pharmaceuticals companies

More PFE From Wires Headlines >

Forbes.com on PFE     RSS

  • Global Lending Drought Continues
    • Syndicated loan volume drops 49% for first half of year.
  • Chantix Gets Boxed In
    • The FDA says patients taking Chantix or Zyban need to be watched for suicide and other psychiatric problems.
  • The Real Reason Big Pharma Mergers Are Wise
    • It has nothing to do with coming up with new products.
  • Ireland's Export Hope
    • Exports by foreign-owned pharma and tech companies offer some salvation to the troubled euro-zone economy.

    PFE Press Releases

    07.01.09  Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer
    07.01.09  Pfizer Invites Public to Listen to Teleconference on Important Update Related to Chantix (R)...
    07.01.09  Pfizer Updates CHANTIX (R) (varenicline) Labeling in the United States
    07.01.09  Pfizer Launches Medicine Assistance Program for Newly Unemployed
    06.30.09  Pfizer Discontinues Phase 3 Trial of Sutent(R) in Metastatic Colorectal Cancer

    More PFE Press Releases >

    PFE Ratios & Returns

    Price-to-sales 2.07
    Return on Equity 13.4
    Operating Margin 42.6
    Profit Margin 17.0%

    More PFE Ratios & Returns >

    PFE Financials

    Sales $47.315 bil
    Profits $8.05 bil
    Assets $122.932 bil
    Employees 81800.0
Pfizer is ranked # 50 on the 2009 Forbes 2000 List

A D V E R T I S E M E N T




СМОТРЕТЬ
презентацию